Belvedere Trading’s Merck MRK Stock Holding History

Belvedere Trading’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,300	Closed	-$144K	–	1258
2022 Q4	$144K	Buy	+1,300	New	+$133K	﹤0.01%	408

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Belvedere Trading's MRK Position: Q1 2015 in Review

Belvedere Trading sold out of Merck (MRK) in Q1 2015, closing a stake of 67,324 shares — an estimated $3.65M sold.

Belvedere Trading first reported a position in MRK in Q4 2014 and held it in 1 quarter. The position peaked at $3.65M in Q4 2014. 1,711 funds tracked by Wall St. Rank hold MRK as of Q1 2015.

Belvedere Trading reported no remaining Merck position as of Q1 2015 after selling out during the quarter.
Belvedere Trading sold 67,324 Merck shares in Q1 2015, an estimated $3.65M.
Belvedere Trading first reported a position in Merck in Q4 2014 and held it in 1 quarter.
Belvedere Trading's Merck position peaked at $3.65M in Q4 2014.
1,711 funds tracked by Wall St. Rank held Merck as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.